EVERYDAY SKIN TINT SPF 30

EVERYDAY SKIN TINT SPF 30 was reported 141 times

EVERYDAY SKIN TINT SPF 30 is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GASTROINTESTINAL MELANOSIS 1 0.0182
1 PINGUECULA 1 0.0094
2 EXPOSURE TO MOULD 1 0.0079
3 APPLICATION SITE NODULE 1 0.0073
4 HEAVY EXPOSURE TO ULTRAVIOLET LIGHT 1 0.0047
5 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 1 0.0043
6 XEROSIS 5 0.0040
7 LENTIGO 2 0.0040
8 SOLAR DERMATITIS 1 0.0037
9 CHEMICAL BURNS OF EYE 1 0.0036
10 PYOGENIC GRANULOMA 1 0.0021
11 HYPEREOSINOPHILIC SYNDROME 1 0.0018
12 APPLICATION SITE DISCHARGE 2 0.0017
13 FUNGAL OESOPHAGITIS 1 0.0014
14 SEBORRHOEIC KERATOSIS 2 0.0014
15 GUTTATE PSORIASIS 1 0.0012
16 SUNBURN 9 0.0012
17 MILIARIA 2 0.0012
18 INJECTION SITE DRYNESS 1 0.0011
19 C-REACTIVE PROTEIN 1 0.0011
20 FACIAL ASYMMETRY 1 0.0010
21 IMMUNE-MEDIATED HEPATITIS 2 0.0010
22 CHEMICAL BURN 1 0.0009
23 MALIGNANT MELANOMA IN SITU 1 0.0008
24 JOINT WARMTH 1 0.0008
25 SKIN DEPIGMENTATION 1 0.0007
26 MENINGITIS VIRAL 1 0.0007
27 VASCULAR INJURY 1 0.0007
28 CONJUNCTIVITIS ALLERGIC 1 0.0007
29 ACNE CYSTIC 2 0.0007
30 SEBORRHOEIC DERMATITIS 1 0.0006
31 ARTHROPOD STING 1 0.0006
32 MALIGNANT MELANOMA 8 0.0006
33 CHEILITIS 3 0.0006
34 NASAL OEDEMA 1 0.0006
35 APPLICATION SITE DISCOLOURATION 2 0.0005
36 DERMATITIS PSORIASIFORM 1 0.0005
37 PIGMENTATION DISORDER 3 0.0005
38 APPLICATION SITE EXFOLIATION 2 0.0005
39 WALKING DISABILITY 1 0.0005
40 APPLICATION SITE SCAB 1 0.0005
41 MELANOCYTIC NAEVUS 2 0.0005
42 METASTATIC MALIGNANT MELANOMA 1 0.0004
43 HAEMANGIOMA 1 0.0004
44 VITILIGO 1 0.0004
45 EYE OEDEMA 1 0.0004
46 SENSITIVE SKIN 3 0.0004
47 ACTINIC KERATOSIS 1 0.0004
48 SKIN DISCOMFORT 1 0.0004
49 APPLICATION SITE HAEMORRHAGE 1 0.0004
50 PHOTOSENSITIVITY REACTION 6 0.0004
51 RED BLOOD CELL COUNT INCREASED 1 0.0004
52 VITREOUS HAEMORRHAGE 1 0.0004
53 CHOLECYSTITIS ACUTE 2 0.0004
54 SKIN HYPERPIGMENTATION 3 0.0003
55 SKIN WARM 2 0.0003
56 TONGUE ULCERATION 1 0.0003
57 ABNORMAL LOSS OF WEIGHT 2 0.0003
58 DERMATITIS 6 0.0003
59 SCLERODERMA 1 0.0003
60 INTENTIONAL UNDERDOSE 2 0.0003
61 OESOPHAGEAL ULCER 1 0.0003
62 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
63 BASAL CELL CARCINOMA 4 0.0003
64 MIOSIS 2 0.0002
65 TRIGGER FINGER 1 0.0002
66 SELF-INJURIOUS IDEATION 1 0.0002
67 OCULAR ICTERUS 1 0.0002
68 APPLICATION SITE ERYTHEMA 6 0.0002
69 SKIN TIGHTNESS 1 0.0002
70 SQUAMOUS CELL CARCINOMA 2 0.0002
71 ENDOMETRIOSIS 1 0.0002
72 INCORRECT DOSAGE ADMINISTERED 1 0.0002
73 ORGANISING PNEUMONIA 1 0.0002
74 APPLICATION SITE SWELLING 1 0.0002
75 AMMONIA INCREASED 1 0.0002
76 ANAL FISTULA 1 0.0002
77 APPLICATION SITE PAIN 4 0.0002
78 HYPERKERATOSIS 1 0.0002
79 ANGIOPATHY 1 0.0002
80 ACUTE PULMONARY OEDEMA 1 0.0002
81 SKIN ATROPHY 1 0.0002
82 RALES 1 0.0002
83 HYPERTRIGLYCERIDAEMIA 1 0.0002
84 CATARACT OPERATION 1 0.0002
85 PRE-EXISTING CONDITION IMPROVED 1 0.0002
86 APPLICATION SITE VESICLES 1 0.0002
87 IMMUNE SYSTEM DISORDER 2 0.0002
88 SKIN MASS 1 0.0001
89 PAIN OF SKIN 4 0.0001
90 DROOLING 1 0.0001
91 ENCEPHALITIS 1 0.0001
92 RETINAL HAEMORRHAGE 1 0.0001
93 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
94 SKIN HAEMORRHAGE 2 0.0001
95 ACNE 10 0.0001
96 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
97 PULMONARY HAEMORRHAGE 1 0.0001
98 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
99 MUSCLE DISORDER 1 0.0001
100 HYPERAESTHESIA 1 0.0001
101 SKIN PLAQUE 1 0.0001
102 CARDIAC MURMUR 1 0.0001
103 NAIL DISORDER 1 0.0001
104 BLOOD CALCIUM INCREASED 1 0.0001
105 IMMUNOSUPPRESSION 1 0.0001
106 LIP DRY 1 0.0001
107 MOOD ALTERED 3 0.0001
108 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
109 SPINAL DISORDER 1 0.0001
110 CHOLESTASIS 2 0.0001
111 PETECHIAE 1 0.0001
112 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
113 SCRATCH 1 0.0001
114 SWELLING FACE 6 0.0001
115 ASPIRATION 1 0.0001
116 NERVE INJURY 1 0.0001
117 RASH PAPULAR 2 0.0001
118 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
119 BLISTER 5 0.0001
120 DERMATITIS CONTACT 1 0.0001
121 SCAB 1 0.0001
122 VASCULITIS 1 0.0001
123 CARDIOMEGALY 1 0.0001
124 APPLICATION SITE IRRITATION 1 0.0001
125 HAIR COLOUR CHANGES 1 0.0001
126 DRY EYE 4 0.0001
127 NODULE 1 0.0001
128 ECZEMA 4 0.0001
129 INCORRECT PRODUCT STORAGE 1 0.0001
130 TACHYPNOEA 1 0.0001
131 SKIN LESION 2 0.0001
132 APPLICATION SITE RASH 1 0.0001
133 SKIN REACTION 1 0.0001
134 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
135 BRONCHOSPASM 1 0.0001
136 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
137 SKIN IRRITATION 3 0.0001
138 SKIN DISCOLOURATION 3 0.0001
139 RASH ERYTHEMATOUS 3 0.0001
140 BACK DISORDER 1 0.0001
141 DRY SKIN 8 0.0001
142 SKIN EXFOLIATION 5 0.0001
143 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
144 SCAR 1 0.0001
145 MUSCULOSKELETAL DISCOMFORT 1 0.0001
146 RASH MACULAR 2 0.0001
147 THIRST 1 0.0001
148 SKIN BURNING SENSATION 4 0.0001
149 GASTROENTERITIS VIRAL 1 0.0001
150 OSTEOMYELITIS 1 0.0001
151 BACTERIAL INFECTION 1 0.0001
152 GASTRIC ULCER 1 0.0001
153 DISABILITY 1 0.0001
154 PSORIATIC ARTHROPATHY 2 0.0000
155 INJURY ASSOCIATED WITH DEVICE 1 0.0000
156 LUNG NEOPLASM MALIGNANT 2 0.0000
157 MOUTH ULCERATION 1 0.0000
158 LIVER FUNCTION TEST INCREASED 1 0.0000
159 SKIN CANCER 1 0.0000
160 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
161 RASH MACULO-PAPULAR 1 0.0000
162 GLOSSODYNIA 1 0.0000
163 APPLICATION SITE PRURITUS 1 0.0000
164 ERYTHEMA 9 0.0000
165 BURNING SENSATION 3 0.0000
166 UNDERDOSE 3 0.0000
167 HYPOPHAGIA 1 0.0000
168 HEPATITIS 1 0.0000
169 INFLAMMATION 2 0.0000
170 PSORIASIS 5 0.0000
171 JAUNDICE 1 0.0000
172 FREQUENT BOWEL MOVEMENTS 1 0.0000
173 WOUND 1 0.0000
174 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
175 EYE PAIN 2 0.0000
176 INTENTIONAL DOSE OMISSION 1 0.0000
177 HYPERSOMNIA 1 0.0000
178 EYE IRRITATION 2 0.0000
179 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
180 INTENTIONAL PRODUCT MISUSE 3 0.0000
181 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
182 ASCITES 1 0.0000
183 PSYCHOTIC DISORDER 1 0.0000
184 URINARY INCONTINENCE 1 0.0000
185 RESPIRATORY DISORDER 1 0.0000
186 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
187 RASH 14 0.0000
188 HEART RATE INCREASED 3 0.0000
189 EXPIRED PRODUCT ADMINISTERED 1 0.0000
190 SKIN DISORDER 1 0.0000
191 URINARY RETENTION 1 0.0000
192 TYPE 2 DIABETES MELLITUS 1 0.0000
193 HAEMATURIA 1 0.0000
194 ILLNESS 3 0.0000
195 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
196 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
197 MYELOSUPPRESSION 1 0.0000
198 DRUG EFFECT INCOMPLETE 1 0.0000
199 HYPERGLYCAEMIA 1 0.0000
200 INJECTION SITE MASS 1 0.0000
201 PRODUCT USE ISSUE 5 0.0000
202 DYSPNOEA EXERTIONAL 1 0.0000
203 PLASMA CELL MYELOMA 1 0.0000
204 DRY MOUTH 2 0.0000
205 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
206 RECTAL HAEMORRHAGE 1 0.0000
207 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
208 TACHYCARDIA 2 0.0000
209 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
210 DEPRESSION 5 0.0000
211 NEPHROLITHIASIS 1 0.0000
212 ADVERSE EVENT 2 0.0000
213 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
214 HYPERSENSITIVITY 4 0.0000
215 BLOOD CHOLESTEROL INCREASED 1 0.0000
216 SWELLING 2 0.0000
217 OCULAR HYPERAEMIA 1 0.0000
218 DYSPHAGIA 2 0.0000
219 DISEASE RECURRENCE 1 0.0000
220 PRODUCTIVE COUGH 1 0.0000
221 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
222 CONTUSION 2 0.0000
223 DRUG INTOLERANCE 2 0.0000
224 SOMNOLENCE 4 0.0000
225 HOSPITALISATION 3 0.0000
226 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
227 RASH PRURITIC 1 0.0000
228 OEDEMA 1 0.0000
229 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
230 URTICARIA 3 0.0000
231 OXYGEN SATURATION DECREASED 1 0.0000
232 FLATULENCE 1 0.0000
233 CONVULSION 1 0.0000
234 SEIZURE 2 0.0000
235 NASAL CONGESTION 1 0.0000
236 JOINT SWELLING 2 0.0000
237 STOMATITIS 1 0.0000
238 CONDITION AGGRAVATED 5 0.0000
239 DISCOMFORT 1 0.0000
240 FEELING HOT 1 0.0000
241 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
242 HYPERHIDROSIS 2 0.0000
243 PRODUCT DOSE OMISSION 1 0.0000
244 BLOOD PRESSURE DECREASED 1 0.0000
245 INJECTION SITE PRURITUS 1 0.0000
246 PRODUCT QUALITY ISSUE 2 0.0000
247 INJECTION SITE REACTION 1 0.0000
248 SLEEP DISORDER 1 0.0000
249 MOBILITY DECREASED 1 0.0000
250 INFECTION 2 0.0000
251 RESPIRATORY FAILURE 1 0.0000
252 EPISTAXIS 1 0.0000
253 HOT FLUSH 1 0.0000
254 DIABETES MELLITUS 1 0.0000
255 INJECTION SITE SWELLING 1 0.0000
256 PRURITUS 5 0.0000
257 PERIPHERAL SWELLING 2 0.0000
258 INJECTION SITE HAEMORRHAGE 1 0.0000
259 INFLUENZA LIKE ILLNESS 1 0.0000
260 ARTHRALGIA 5 0.0000
261 ABDOMINAL DISCOMFORT 2 0.0000
262 MYALGIA 2 0.0000
263 BALANCE DISORDER 1 0.0000
264 PRODUCT STORAGE ERROR 1 0.0000
265 MUSCULOSKELETAL STIFFNESS 1 0.0000
266 HEADACHE 7 0.0000
267 GASTROINTESTINAL DISORDER 1 0.0000
268 SUICIDAL IDEATION 1 0.0000
269 MUSCLE SPASMS 2 0.0000
270 WEIGHT DECREASED 3 0.0000
271 COUGH 3 0.0000
272 ANXIETY 3 0.0000
273 PULMONARY EMBOLISM 1 0.0000
274 MIGRAINE 1 0.0000
275 ATRIAL FIBRILLATION 1 0.0000
276 DYSPEPSIA 1 0.0000
277 FLUSHING 1 0.0000
278 PAIN 6 0.0000
279 ABDOMINAL PAIN UPPER 2 0.0000
280 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
281 ABDOMINAL DISTENSION 1 0.0000
282 HAEMORRHAGE 1 0.0000
283 OVERDOSE 2 0.0000
284 MALAISE 4 0.0000
285 SEPSIS 1 0.0000
286 ASTHMA 1 0.0000
287 MUSCULAR WEAKNESS 1 0.0000
288 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
289 DECREASED APPETITE 2 0.0000
290 BACK PAIN 2 0.0000
291 PALPITATIONS 1 0.0000
292 DISEASE PROGRESSION 1 0.0000
293 OFF LABEL USE 7 0.0000
294 ASTHENIA 3 0.0000
295 DIARRHOEA 5 0.0000
296 DEHYDRATION 1 0.0000
297 NEUTROPENIA 1 0.0000
298 VISION BLURRED 1 0.0000
299 PRODUCT DOSE OMISSION ISSUE 2 0.0000
300 PAIN IN EXTREMITY 2 0.0000
301 BLOOD PRESSURE INCREASED 1 0.0000
302 ACUTE KIDNEY INJURY 1 0.0000
303 FATIGUE 5 0.0000
304 CONFUSIONAL STATE 1 0.0000
305 PNEUMONIA 2 0.0000
306 FALL 2 0.0000
307 CEREBROVASCULAR ACCIDENT 1 0.0000
308 PYREXIA 2 0.0000
309 COVID-19 1 0.0000
310 NASOPHARYNGITIS 1 0.0000
311 CHEST PAIN 1 0.0000
312 BLOOD GLUCOSE INCREASED 1 0.0000
313 ANAEMIA 1 0.0000
314 GAIT DISTURBANCE 1 0.0000
315 ALOPECIA 1 0.0000
316 HYPOTENSION 1 0.0000
317 HYPERTENSION 1 0.0000
318 CONSTIPATION 1 0.0000
319 WEIGHT INCREASED 1 0.0000
320 ABDOMINAL PAIN 1 0.0000
321 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
322 DRUG INEFFECTIVE 5 0.0000
323 NAUSEA 3 0.0000
324 INSOMNIA 1 0.0000
325 DYSPNOEA 2 0.0000
326 INJECTION SITE PAIN 1 0.0000
327 DEATH 2 0.0000
328 VOMITING 1 0.0000